Keys to the coronavirus: Single dose vaccines

Administration of a single dose Janssen vaccine has begun. Clinical trials have shown that a single dose is sufficient to protect 67% against infection. Like the Astrazeneca and Sputnik vaccines, the vaccine is adenoviral, i.e., it carries the information needed to produce the coronavirus S protein.


Buletina

Bidali zure helbide elektronikoa eta jaso asteroko buletina zure sarrera-ontzian

Bidali